Preventing relapse in melanoma.

被引:2
作者
Stebbing J. [1 ]
Gore M. [1 ]
机构
[1] Institute of Cancer Research, The Royal Marsden Hospital, Fulham Road, London
关键词
Melanoma; AJCC Stage; Proc ASCO; Melanoma Vaccine; Autologous Melanoma Cell;
D O I
10.1007/s11912-000-0068-y
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:205 / 208
页数:3
相关论文
共 99 条
  • [1] Reintgen D(1997)The adjuvant treatment of malignant melanoma J Flor Med Assoc 84 147-152
  • [2] Kirkwood J(1984)Late recurrence of cutaneous malignant melanoma JAMA 251 1859-1862
  • [3] Koh MK(1998)Adjuvant IFNa2 therapy of melanoma Lancet 351 1901-1903
  • [4] Sober AJ(1998)Adjuvant therapy of melanoma Semin Surg Oncol 14 302-310
  • [5] Fitzpatrick TB(1996)High dose chemotherapy and autologous stem cell support for patients with malignant melanoma Bone Marrow Transplant 17 903-906
  • [6] Kirkwood JM(1996)Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial EST 1684 J Clin Oncol 14 7-17
  • [7] Agarwala SS(1995)Randomized, surgical adjuvant clinical trial of recombinant interferon a2a in selected patients with malignant melanoma J Clin Oncol 13 2776-2782
  • [8] Kirkwood JM(1999)Adjuvant interferon in the treatment of melanoma Br J Cancer 80 1679-1680
  • [9] Meisenberg B(1999)Preliminary analysis of the E 1690/S 9111/C9190 Intergroup postoperative adjuvant trial of high-and low-dose IFNa2b (HDI and LDI) in high-risk primary or lymph node metastatic melanoma [abstract] Proc ASCO 18 537a-537a
  • [10] Kirkwood JM(1998)Randomised trial of interferon-a2a as adjuvant therapy in resected primary melanoma thicker than 1.5mm without clinically detectable lymph node metastases Lancet 351 1905-1910